Acctrue Technology, Inc. is a global technology company specializing in providing total solutions for Track & Trace and Serialization projects to companies. Founded in 1998 with headquarters in Beijing, the company initially focused on quality tracking application and later became the first enterprise to implement a pharmaceutical electronic monitoring code system in China. Over the years, Acctrue has gained significant traction, having implemented serialization projects for more than 3000 pharmaceutical clients since 2005. The company's impressive track record has led to 18 of the top 25 global pharmaceutical companies choosing Acctrue's solution to implement their global Track & Trace projects, ensuring compliance with the CFDA requirement. With 17 years of continuous innovation and dedication, Acctrue's software is now utilized in over 150,000 production lines across 16 different industries. Recently, the company received a Series C investment on 09 June 2021, with Cowin Capital as the investor. Acctrue's successful track record, innovative technology, and substantial global presence position it as a promising investment opportunity in the enterprise industry.
No recent news or press coverage available for Acctrue Technology, Inc..